Trials / Withdrawn
WithdrawnNCT00299845
Randomized Trial for Pharmacogenomics-based Proton Pump Inhibitor Therapy in Children
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Osaka University · Academic / Other
- Sex
- All
- Age
- 1 Year – 15 Years
- Healthy volunteers
- Not accepted
Summary
Proton pump inhibitors are administered to children as off-label use in Japan. The purpose of this study is to evaluate the effects of CYP2C19 genotypes on pharmacokinetic /pharmacodynamic profiles of PPI in children. The results will provide the beneficial information for the individualized medicine of PPI in children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lansoprazole |
Timeline
- First posted
- 2006-03-07
- Last updated
- 2012-10-11
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00299845. Inclusion in this directory is not an endorsement.